The single-dose Johnson & Johnson Covid-19 vaccine – known as Janssen, which is the vaccine arm of Johnson & Johnson – has been approved for use in the UK by regulators, the country’s Department of Health announced Friday.
The UK government has secured 20 million doses of the shot and it is expected to be available from later this year, the department said in a statement.
“The Medicines and Healthcare products Regulatory Agency (MHRA) has today announced that the COVID-19 Vaccine Janssen meets the expected standards of safety, quality and effectiveness,” it said.
UK Prime Minister Boris Johnson welcomed the news on Twitter, saying it is “another boost to our hugely successful vaccination programme.”
He added: “As we encourage everyone to get their jabs, the single-dose Janssen vaccine will play an important role in helping us protect people from the virus. When you get the call, get the jab.”
